Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artiva Biotherapeutics, Inc.

4.44
-0.6200-12.25%
Post-market: 4.530.0900+2.03%19:43 EDT
Volume:182.16K
Turnover:842.90K
Market Cap:107.84M
PE:-0.39
High:5.30
Open:5.12
Low:4.18
Close:5.06
Loading ...

Artiva Biotherapeutics Expands Board of Directors With Appointment of Dan Baker, M.d.

THOMSON REUTERS
·
30 Jan

Artiva Biotherapeutics Expands Board of Directors with Appointment of Dan Baker, M.D.

GlobeNewswire
·
30 Jan

HC Wainwright Initiates Artiva Biotherapeutics at Buy With $20 Price Target

MT Newswires Live
·
30 Dec 2024

BUZZ-H.C. Wainwright starts coverage of Artiva Biotherapeutics with 'buy' rating

Reuters
·
30 Dec 2024

Artiva Biotherapeutics Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
30 Dec 2024

U.S. RESEARCH ROUNDUP- Arcutis Biotherapeutics, Artiva Biotherapeutics, Nuvalent

Reuters
·
30 Dec 2024

Artiva Biotherapeutics initiated with a Buy at H.C. Wainwright

TIPRANKS
·
30 Dec 2024

Artiva Biotherapeutics, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
30 Dec 2024

AFMD Stock Down Despite FDA's RMAT Status for Lymphoma Therapy

Zacks
·
06 Dec 2024

Artiva Biotherapeutics Reports Q3 2024 Financial Results

TIPRANKS
·
14 Nov 2024

Artiva Biotherapeutics Price Target Maintained With a $23.00/Share by Needham

Dow Jones
·
13 Nov 2024

Artiva Biotherapeutics, Inc.: Strong Buy Rating Supported by Robust Autoimmune Pipeline and Financial Stability

TIPRANKS
·
13 Nov 2024

Artiva Biotherapeutics, Inc. (ARTV) Receives a Buy from TD Cowen

TIPRANKS
·
13 Nov 2024

Artiva Biotherapeutics reports Q3 EPS (92c), consensus (91c)

TIPRANKS
·
13 Nov 2024

Artiva Biotherapeutics Q3 EPS $(0.92) Misses $(0.91) Estimate

Benzinga
·
13 Nov 2024

Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

GlobeNewswire
·
13 Nov 2024